Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Must have histological or cytological confirmed diagnosis of locally advanced or metastatic adenocarcinoma of the pancreas, which has progressed on or after one line of chemotherapy
ECOG Performance status 0-1
Adequate organ functions
Measurable disease
You may not be if
Suspected or known CNS metastasis
Participants with active, known, or suspected autoimmune disease
Uncontrolled or significant cardiovascular disease
Prior exposure to selected immune cell-modulating antibody regimens
Clareo Health | A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
